National Cancer Institute Drug Information System
| Knowledge Source Identification | |
|---|---|
| Knowledge source name | National Cancer Institute Drug Information System |
| Abbreviated name | NCI DIS |
| Owner/Developer | National Cancer Institute |
| Abbreviated owner | NCI |
| Country | United States of America |
| Languages | English |
| URL | http://tccc.iesl.forth.gr/education/local/quantum/molecular_modeling/dis_documents/dis.html |
| Description | Since 1955, the National Cancer Institute has conducted extensive testing of materials for possible activity against different forms of cancer. Over 400,000 compounds have been aquired and the information management problems associated with this effort are best handled by a computer system. The NCI Drug Information System ( DIS ) was set up in 1980 in order to keep track of acquisition, storage, shipping, and testing of drugs at the National Cancer Institute. The DIS consists of 2 major sub-systems: The Pre-Registry and the Drug sub-systems. The Pre-Registry sub-system handles compound acquisition and only is of interest to those directly involved in the acquisition process. |
| Knowledge Source Category | |
| Category | Information System |
| Sub categories | Database |
| Knowledge Dissemination and Sharing | |
| Dissemination channel | Website |
| Targeted audience (specified/objective analysis) | Not specified |
| Users access | Open access, Free access |
| Knowledge Characterization | |
| 3Rs relevance | Reduction |
| Purpose | Documentation and information |
| Technology/Tools | Non-testing methods (in silico) |